Overview

Duloxetine for PHN

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
In this study, the investigators aim to investigate the preventive efficacy of prophylactic oral duloxetine during acute herpes zoster on postherpetic neuralgia and its safety.
Phase:
N/A
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborators:
Baoding First Central Hospital
Beijing Tsinghua Chang Gung Hospital
Cangzhou Central Hospital
China-Japan Friendship Hospital
First Hospital of China Medical University
Fujian Provincial Hospital
Huai'an Second People's Hospital
Linfen Fourth People's Hospital
Peking University International Hospital
Qingdao Municipal Hospital (Group)
Second Affiliated Hospital of Zhengzhou University
Shandong Provincial Hospital
Taiyuan Central Hospital of Shanxi Medical University
The People's Hospital of Fujian Province
The Second Affiliated Hospital of Zhengzhou University
Tianjin First Central Hospital
Tianjin Huanhu Hospital
Tianjin Medical University Second Hospital
Treatments:
Duloxetine Hydrochloride